23 years of historical data (2003–2025) · Healthcare · Drug Manufacturers - Specialty & Generic
Percentile shows where the current value sits in 30-year historical distribution. Sparklines show 5-year trend.
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
Viatris Inc. currently has a negative P/E ratio, indicating the company is operating at a loss on a trailing-twelve-month basis. On a free-cash-flow basis, the stock trades at 9.2x P/FCF, 42% above the 5-year average of 6.5x.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $17.9B | $14.6B | $14.9B | $13.1B | $13.5B | $16.4B | $11.3B | $10.4B | $14.1B | $22.7B | $19.9B |
| Enterprise Value | $31.3B | $27.9B | $28.4B | $30.5B | $31.8B | $39.0B | $36.6B | $22.8B | $27.5B | $37.1B | $34.3B |
| P/E Ratio → | -5.12 | — | — | 239.07 | 6.51 | — | — | 670.00 | 40.10 | 32.55 | 41.47 |
| P/S Ratio | 1.25 | 1.02 | 1.01 | 0.85 | 0.83 | 0.91 | 0.94 | 0.90 | 1.23 | 1.91 | 1.79 |
| P/B Ratio | 1.22 | 0.99 | 0.80 | 0.64 | 0.64 | 0.80 | 0.49 | 0.87 | 1.16 | 1.71 | 1.79 |
| P/FCF | 9.24 | 7.52 | 7.52 | 5.62 | 5.40 | 6.52 | 20.46 | 7.43 | 6.74 | 12.69 | 11.99 |
| P/OCF | 7.73 | 6.29 | 6.45 | 4.67 | 4.52 | 5.42 | 9.15 | 5.76 | 6.01 | 11.00 | 9.70 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
Viatris Inc.'s enterprise value stands at 231.2x EBITDA, 380% above its 5-year average of 48.1x. The Healthcare sector median is 14.2x, placing the stock at a 1526% premium on an enterprise-value basis.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 1.95 | 1.93 | 1.97 | 1.96 | 2.18 | 3.06 | 1.99 | 2.41 | 3.11 | 3.10 |
| EV / EBITDA | 231.16 | 206.57 | 9.79 | 8.68 | 6.85 | 8.72 | 18.24 | 8.35 | 9.12 | 11.43 | 15.45 |
| EV / EBIT | — | — | — | 39.24 | 9.34 | — | — | 33.99 | 32.73 | 25.79 | 59.55 |
| EV / FCF | — | 14.42 | 14.38 | 13.10 | 12.68 | 15.56 | 66.44 | 16.33 | 13.17 | 20.73 | 20.72 |
Margins and return-on-capital ratios measuring operating efficiency
Viatris Inc. earns an operating margin of -18.6%. Operating margins have compressed from 5.0% to -18.6% over the past 3 years, signaling potential cost pressures or competitive headwinds. A negative ROE of -21.1% indicates the company is currently destroying shareholder equity.
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1% | 35.1% | 38.2% | 41.7% | 40.0% | 31.2% | 31.8% | 33.9% | 35.0% | 40.2% | 42.4% |
| Operating Margin | -18.6% | -18.6% | 0.1% | 5.0% | 9.9% | -0.2% | -1.8% | 6.2% | 7.9% | 12.1% | 6.3% |
| Net Profit Margin | -24.6% | -24.6% | -4.3% | 0.4% | 12.8% | -7.1% | -5.6% | 0.1% | 3.1% | 5.8% | 4.3% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -21.1% | -21.1% | -3.2% | 0.3% | 10.0% | -5.8% | -3.8% | 0.1% | 2.8% | 5.7% | 4.6% |
| ROA | -8.9% | -8.9% | -1.4% | 0.1% | 4.0% | -2.2% | -1.4% | 0.1% | 1.0% | 2.0% | 1.7% |
| ROIC | -6.6% | -6.6% | 0.0% | 1.5% | 2.9% | -0.1% | -0.4% | 2.1% | 2.5% | 4.0% | 2.5% |
| ROCE | -8.1% | -8.1% | 0.0% | 1.8% | 3.7% | -0.1% | -0.5% | 2.7% | 3.1% | 4.9% | 2.9% |
Solvency and debt-coverage ratios — lower is generally safer
Viatris Inc. carries a Debt/EBITDA ratio of 108.7x, which is highly leveraged (3282% above the sector average of 3.2x). Net debt stands at $13.4B ($14.7B total debt minus $1.3B cash).
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 1.00 | 1.00 | 0.77 | 0.90 | 0.93 | 1.14 | 1.14 | 1.09 | 1.14 | 1.10 | 1.39 |
| Debt / EBITDA | 108.74 | 108.74 | 4.93 | 5.24 | 4.21 | 5.22 | 13.05 | 4.73 | 4.58 | 4.52 | 6.96 |
| Net Debt / Equity | — | 0.91 | 0.73 | 0.85 | 0.87 | 1.11 | 1.10 | 1.05 | 1.10 | 1.08 | 1.30 |
| Net Debt / EBITDA | 98.77 | 98.77 | 4.67 | 4.96 | 3.93 | 5.07 | 12.62 | 4.55 | 4.45 | 4.43 | 6.51 |
| Debt / FCF | — | 6.89 | 6.86 | 7.47 | 7.28 | 9.04 | 45.98 | 8.91 | 6.43 | 8.03 | 8.74 |
| Interest Coverage | -6.78 | -6.78 | -0.13 | 1.35 | 5.75 | -0.04 | -0.45 | 1.30 | 1.55 | 2.69 | 1.27 |
Short-term solvency ratios and asset-utilisation metrics
A current ratio of 1.30x means Viatris Inc. can comfortably meet its short-term obligations, though there is limited excess liquidity. The quick ratio of 0.74x is notably lower than the current ratio, indicating a significant portion of current assets is tied up in inventory. The current ratio has declined from 1.67x to 1.30x over the past 3 years.
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.30 | 1.30 | 1.65 | 1.67 | 1.58 | 1.10 | 1.22 | 1.21 | 1.39 | 1.13 | 1.49 |
| Quick Ratio | 0.74 | 0.74 | 0.98 | 1.22 | 1.05 | 0.70 | 0.70 | 0.73 | 0.83 | 0.73 | 1.01 |
| Cash Ratio | 0.21 | 0.21 | 0.19 | 0.15 | 0.22 | 0.09 | 0.10 | 0.10 | 0.10 | 0.06 | 0.21 |
| Asset Turnover | — | 0.38 | 0.36 | 0.32 | 0.33 | 0.33 | 0.19 | 0.37 | 0.35 | 0.33 | 0.32 |
| Inventory Turnover | 2.32 | 2.32 | 2.37 | 2.59 | 2.77 | 3.09 | 1.49 | 2.85 | 2.88 | 2.80 | 2.60 |
| Days Sales Outstanding | — | 85.43 | 87.22 | 95.60 | 92.98 | 87.06 | 148.00 | 97.08 | 77.14 | 97.26 | 99.36 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Viatris Inc. returns 5.9% to shareholders annually — split between a 3.1% dividend yield and 2.8% buyback yield.
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 3.1% | 3.9% | 3.9% | 4.4% | 4.3% | 2.4% | — | — | — | — | — |
| Payout Ratio | — | — | — | 1052.3% | 28.0% | — | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | — | — | — | 0.4% | 15.4% | — | — | 0.1% | 2.5% | 3.1% | 2.4% |
| FCF Yield | 10.8% | 13.3% | 13.3% | 17.8% | 18.5% | 15.3% | 4.9% | 13.5% | 14.8% | 7.9% | 8.3% |
| Buyback Yield | 2.8% | 3.4% | 1.7% | 1.9% | 0.0% | 0.1% | 0.0% | 0.0% | 3.1% | 2.2% | 0.1% |
| Total Shareholder Yield | 5.9% | 7.3% | 5.6% | 6.3% | 4.3% | 2.5% | 0.0% | 0.0% | 3.1% | 2.2% | 0.1% |
| Shares Outstanding | — | $1.2B | $1.2B | $1.2B | $1.2B | $1.2B | $601M | $517M | $517M | $537M | $521M |
Compare VTRS with 10 similar companies in its peer group
| Company | Market Cap | P/E | EV/EBITDA | P/FCF | Gross Margin | Op Margin | ROE | ROIC | Debt/EBITDA |
|---|---|---|---|---|---|---|---|---|---|
| $18B | -5.1 | 231.2 | 9.2 | 35.1% | -18.6% | -21.1% | -6.6% | 108.7 | |
| $37B | 26.2 | 16.0 | 31.9 | 51.8% | 12.5% | 20.7% | 7.7% | 5.5 | |
| $5B | 73.7 | — | 18.9 | 36.9% | -0.2% | 15.7% | -0.2% | — | |
| $1B | -1.0 | 7.1 | 9.8 | 35.1% | 8.1% | -39.3% | 3.7% | 5.8 | |
| $143B | 18.5 | 10.3 | 15.8 | 70.3% | 24.7% | 8.9% | 7.5% | 3.3 | |
| $281B | 15.6 | 10.8 | 22.8 | 72.0% | 36.2% | 36.9% | 22.0% | 1.7 | |
| $383B | 91.4 | 15.8 | 21.5 | 70.2% | 32.8% | 6214.7% | 23.9% | 2.4 | |
| $65M | 11.0 | — | — | — | — | 5.1% | -43.0% | — | |
| $90B | 19.6 | 13.2 | 15.8 | 3.6% | 1.6% | — | 254.1% | 1.2 | |
| $52B | 34.4 | 18.8 | 28.2 | 3.7% | 1.0% | — | 3378.7% | 3.0 | |
| $125B | 70.7 | 14.0 | 16.1 | 13.8% | 2.6% | 2.3% | 5.0% | 6.2 | |
| Healthcare Median | — | 22.1 | 14.2 | 18.5 | 63.9% | -4.3% | -32.6% | -11.6% | 3.2 |
Peer selection based on competitive and market overlap. Compare multiple stocks →
Includes 30+ ratios · 22 years · Updated daily
Deep dive into VTRS consensus models and risk factors.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying VTRS stock.
Viatris Inc.'s current P/E ratio is -5.1x. The historical average is 28.9x.
Viatris Inc.'s current EV/EBITDA is 231.2x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 11.9x.
Viatris Inc.'s return on equity (ROE) is -21.1%. The historical average is 3.2%.
Based on historical data, Viatris Inc. is trading at a P/E of -5.1x. Compare with industry peers and growth rates for a complete picture.
Viatris Inc.'s current dividend yield is 3.12%.
Viatris Inc. has 35.1% gross margin and -18.6% operating margin.
Viatris Inc.'s Debt/EBITDA ratio is 108.7x, indicating high leverage. A ratio above 4x may signal elevated financial risk.